Question | Discussion | References | CME Credit

Case 2: Antiretroviral Regimens

You answered:

B Tenofovir-emtricitabine (Truvada) plus ritonavir (Norvir) plus darunavir (Prezista)

This answer is correct. This regimen of tenofovir-emtricitabine plus ritonavir plus darunavir is considered a preferred regimen based on data that have shown excellent virologic responses and low frequency of side effects with this regimen.


[Back to Case 2 Question | Proceed to Case 2 Discussion]